Revisiting concepts of evidence in implementation science.


Journal

Implementation science : IS
ISSN: 1748-5908
Titre abrégé: Implement Sci
Pays: England
ID NLM: 101258411

Informations de publication

Date de publication:
12 04 2022
Historique:
received: 30 10 2021
accepted: 04 04 2022
entrez: 13 4 2022
pubmed: 14 4 2022
medline: 15 4 2022
Statut: epublish

Résumé

Evidence, in multiple forms, is a foundation of implementation science. For public health and clinical practice, evidence includes the following: type 1 evidence on etiology and burden; type 2 evidence on effectiveness of interventions; and type 3: evidence on dissemination and implementation (D&I) within context. To support a vision for development and use of evidence in D&I science that is more comprehensive and equitable (particularly for type 3 evidence), this article aims to clarify concepts of evidence, summarize ongoing debates about evidence, and provide a set of recommendations and tools/resources for addressing the "how-to" in filling evidence gaps most critical to advancing implementation science. Because current conceptualizations of evidence have been relatively narrow and insufficiently characterized in our opinion, we identify and discuss challenges and debates about the uses, usefulness, and gaps in evidence for implementation science. A set of questions is proposed to assist in determining when evidence is sufficient for dissemination and implementation. Intersecting gaps include the need to (1) reconsider how the evidence base is determined, (2) improve understanding of contextual effects on implementation, (3) sharpen the focus on health equity in how we approach and build the evidence-base, (4) conduct more policy implementation research and evaluation, and (5) learn from audience and stakeholder perspectives. We offer 15 recommendations to assist in filling these gaps and describe a set of tools for enhancing the evidence most needed in implementation science. To address our recommendations, we see capacity as a necessary ingredient to shift the field's approach to evidence. Capacity includes the "push" for implementation science where researchers are trained to develop and evaluate evidence which should be useful and feasible for implementers and reflect community or stakeholder priorities. Equally important, there has been inadequate training and too little emphasis on the "pull" for implementation science (e.g., training implementers, practice-based research). We suggest that funders and reviewers of research should adopt and support a more robust definition of evidence. By critically examining the evolving nature of evidence, implementation science can better fulfill its vision of facilitating widespread and equitable adoption, delivery, and sustainment of scientific advances.

Sections du résumé

BACKGROUND
Evidence, in multiple forms, is a foundation of implementation science. For public health and clinical practice, evidence includes the following: type 1 evidence on etiology and burden; type 2 evidence on effectiveness of interventions; and type 3: evidence on dissemination and implementation (D&I) within context. To support a vision for development and use of evidence in D&I science that is more comprehensive and equitable (particularly for type 3 evidence), this article aims to clarify concepts of evidence, summarize ongoing debates about evidence, and provide a set of recommendations and tools/resources for addressing the "how-to" in filling evidence gaps most critical to advancing implementation science.
MAIN TEXT
Because current conceptualizations of evidence have been relatively narrow and insufficiently characterized in our opinion, we identify and discuss challenges and debates about the uses, usefulness, and gaps in evidence for implementation science. A set of questions is proposed to assist in determining when evidence is sufficient for dissemination and implementation. Intersecting gaps include the need to (1) reconsider how the evidence base is determined, (2) improve understanding of contextual effects on implementation, (3) sharpen the focus on health equity in how we approach and build the evidence-base, (4) conduct more policy implementation research and evaluation, and (5) learn from audience and stakeholder perspectives. We offer 15 recommendations to assist in filling these gaps and describe a set of tools for enhancing the evidence most needed in implementation science.
CONCLUSIONS
To address our recommendations, we see capacity as a necessary ingredient to shift the field's approach to evidence. Capacity includes the "push" for implementation science where researchers are trained to develop and evaluate evidence which should be useful and feasible for implementers and reflect community or stakeholder priorities. Equally important, there has been inadequate training and too little emphasis on the "pull" for implementation science (e.g., training implementers, practice-based research). We suggest that funders and reviewers of research should adopt and support a more robust definition of evidence. By critically examining the evolving nature of evidence, implementation science can better fulfill its vision of facilitating widespread and equitable adoption, delivery, and sustainment of scientific advances.

Identifiants

pubmed: 35413917
doi: 10.1186/s13012-022-01201-y
pii: 10.1186/s13012-022-01201-y
pmc: PMC9004065
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

26

Subventions

Organisme : NIH HHS
ID : P50CA244690
Pays : United States
Organisme : NIH HHS
ID : R25DK123008
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA244431
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK056341
Pays : United States
Organisme : NIH HHS
ID : P50CA244688
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA244688
Pays : United States
Organisme : NIH HHS
ID : P30DK092950
Pays : United States
Organisme : ACL HHS
ID : U48DP006395
Pays : United States
Organisme : NIH HHS
ID : R01CA255382
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK092950
Pays : United States
Organisme : NIH HHS
ID : P50CA244431
Pays : United States

Informations de copyright

© 2022. The Author(s).

Références

BMJ. 2021 Sep 30;374:n2061
pubmed: 34593508
Implement Sci. 2017 Feb 2;12(1):10
pubmed: 28148305
Annu Rev Public Health. 2015 Mar 18;36:307-23
pubmed: 25581153
Annu Rev Public Health. 2018 Apr 1;39:27-53
pubmed: 29166243
Implement Sci. 2021 Jan 7;16(1):7
pubmed: 33413489
J Public Health Manag Pract. 2008 Mar-Apr;14(2):193-8
pubmed: 18287927
Implement Sci. 2020 Jun 19;15(1):47
pubmed: 32560661
BMC Public Health. 2018 Jul 13;18(1):869
pubmed: 30005611
Implement Sci. 2017 Nov 21;12(1):137
pubmed: 29162150
Am J Public Health. 2009 Sep;99(9):1576-83
pubmed: 19608941
Annu Rev Public Health. 1996;17:511-38
pubmed: 8724238
Int J Behav Med. 2020 Feb;27(1):3-20
pubmed: 32060805
Transl Behav Med. 2017 Sep;7(3):593-601
pubmed: 27030472
Implement Sci. 2018 Dec 27;13(1):154
pubmed: 30587195
J Public Health Manag Pract. 2016 Jan-Feb;22 Suppl 1:S8-S10
pubmed: 26599034
J Epidemiol Community Health. 2013 Feb;67(2):190-3
pubmed: 22875078
Am J Public Health. 2019 Jan;109(S1):S94-S101
pubmed: 30699023
Annu Rev Public Health. 2004;25:25-52
pubmed: 15015911
Aust N Z J Public Health. 1999 Aug;23(4):436-40
pubmed: 10462873
Annu Rev Public Health. 2011;32:381-98
pubmed: 21091195
Implement Sci. 2014 Jan 08;9:1
pubmed: 24398253
BMJ. 2004 Oct 30;329(7473):990-1
pubmed: 15514320
JAMA. 2021 Feb 16;325(7):627-628
pubmed: 33492333
J Epidemiol Community Health. 2004 Sep;58(9):788-93
pubmed: 15310806
Annu Rev Public Health. 2007;28:413-33
pubmed: 17150029
Implement Sci Commun. 2021 Sep 08;2(1):99
pubmed: 34496978
Implement Sci. 2021 Mar 19;16(1):28
pubmed: 33740999
Annu Rev Public Health. 2004;25:281-302
pubmed: 15015921
Am J Prev Med. 2007 Aug;33(2):155-61
pubmed: 17673104
Implement Sci. 2013 Jun 10;8:63
pubmed: 23758952
Am J Public Health. 2010 Apr 1;100 Suppl 1:S40-6
pubmed: 20147663
Semin Perinatol. 1997 Feb;21(1):3-5
pubmed: 9190027
Ethn Dis. 2021 Jan 21;31(1):133-138
pubmed: 33519163
Implement Sci. 2012 Mar 20;7:20
pubmed: 22433980
Am J Clin Nutr. 2003 Sep;78(3 Suppl):514S-516S
pubmed: 12936942
BMC Health Serv Res. 2014 Jan 03;14:2
pubmed: 24383766
Intensive Crit Care Nurs. 1998 Oct;14(5):231-8
pubmed: 9849236
Health Care Manage Rev. 2008 Oct-Dec;33(4):300-7
pubmed: 18815495
J Public Health Manag Pract. 2018 Mar/Apr;24(2):102-111
pubmed: 28885319
Public Health Rep. 2010 Sep-Oct;125(5):736-42
pubmed: 20873290
J Clin Transl Sci. 2019 Jun;3(2-3):53-58
pubmed: 31528365
J Public Health Policy. 2020 Dec;41(4):410-420
pubmed: 32826935
J Adv Nurs. 2004 Jul;47(1):81-90
pubmed: 15186471
Implement Sci. 2021 Aug 3;16(1):75
pubmed: 34344411
Implement Sci Commun. 2020 Feb 26;1:17
pubmed: 32885179
Am J Public Health. 2013 Sep;103(9):1693-9
pubmed: 23865659
Int J Behav Nutr Phys Act. 2017 Sep 29;14(1):133
pubmed: 28962580
J Health Serv Res Policy. 2005 Jul;10 Suppl 1:21-34
pubmed: 16053581
Arch Intern Med. 2008 Jan 28;168(2):133-5
pubmed: 18227357
Implement Sci. 2020 Oct 30;15(1):97
pubmed: 33126909
J Acquir Immune Defic Syndr. 2019 Dec;82 Suppl 3:S199-S205
pubmed: 31764255
Implement Sci. 2019 Mar 12;14(1):26
pubmed: 30866982
Implement Sci. 2022 Jan 31;17(1):13
pubmed: 35101088
Cancer Causes Control. 2018 Mar;29(3):363-369
pubmed: 29417296
BMC Public Health. 2014 Jul 18;14:728
pubmed: 25034534
Implement Sci. 2021 Apr 7;16(1):36
pubmed: 33827716
Am J Public Health. 2015 Sep;105(9):1744-7
pubmed: 26180955
Annu Rev Public Health. 2019 Apr 1;40:105-125
pubmed: 30601726
PLoS One. 2014 Aug 14;9(8):e103754
pubmed: 25121789
Annu Rev Public Health. 2017 Mar 20;38:1-22
pubmed: 28384085
BMC Med. 2018 Apr 30;16(1):63
pubmed: 29706132
Public Health. 2005 Sep;119(9):751-7
pubmed: 15913681
MMWR Morb Mortal Wkly Rep. 2011 May 20;60(19):619-23
pubmed: 21597455
Appl Ergon. 2019 May;77:70-82
pubmed: 30832780
Arch Dis Child. 2005 Aug;90(8):840-4
pubmed: 16040885
Implement Sci. 2013 Oct 02;8:117
pubmed: 24088228
Am J Prev Med. 2015 May;48(5):543-51
pubmed: 25891053
BMJ. 2021 Aug 3;374:n1679
pubmed: 34344699
Implement Sci. 2016 Jan 04;11:1
pubmed: 26727969
Eval Rev. 2017 Aug;41(4):283-325
pubmed: 27580622
Evid Based Med. 2014 Dec;19(6):201-3
pubmed: 24799447
Rev Epidemiol Sante Publique. 2013 Aug;61 Suppl 3:S127-32
pubmed: 23849293
Fam Pract. 2008 Dec;25 Suppl 1:i20-4
pubmed: 18794201
Implement Sci. 2013 Aug 19;8:90
pubmed: 23958445
Eval Health Prof. 2006 Mar;29(1):126-53
pubmed: 16510882
BMC Health Serv Res. 2019 Mar 25;19(1):189
pubmed: 30909897
AACN Clin Issues. 2001 Nov;12(4):468-76
pubmed: 11759419
Annu Rev Public Health. 2019 Apr 1;40:423-442
pubmed: 30633710
J Nurs Manag. 2008 May;16(4):404-8
pubmed: 18405256
Implement Sci. 2018 Jul 30;13(1):103
pubmed: 30060744
J Epidemiol Community Health. 2005 Aug;59(8):632-7
pubmed: 16020638
PLoS Med. 2005 May;2(5):e107
pubmed: 15916456
Adm Policy Ment Health. 2011 Jan;38(1):4-23
pubmed: 21197565
Implement Sci. 2019 Jun 6;14(1):58
pubmed: 31171014
J R Soc Med. 1995 Nov;88(11):620-4
pubmed: 8544145
BMJ. 2013 Nov 20;347:f6753
pubmed: 24259324
Qual Health Res. 2005 Jan;15(1):129-38
pubmed: 15574720
PLoS One. 2019 Nov 13;14(11):e0216971
pubmed: 31721784
Am J Prev Med. 2001 Apr;20(3 Suppl):13-20
pubmed: 11306228
Implement Sci. 2020 Jan 9;15(1):2
pubmed: 31915032
J Epidemiol Community Health. 2004 Jul;58(7):538-45
pubmed: 15194712
Annu Rev Public Health. 2019 Apr 1;40:45-63
pubmed: 30664836
Lancet HIV. 2019 Nov;6(11):e800-e806
pubmed: 31570273
Ethn Dis. 2019 Feb 21;29(Suppl 1):83-92
pubmed: 30906154
Am J Prev Med. 2006 Oct;31(4 Suppl):S24-34
pubmed: 16979467
Sociol Health Illn. 2006 Jul;28(5):513-32
pubmed: 16910945
MMWR Morb Mortal Wkly Rep. 1999 Apr 2;48(12):241-3
pubmed: 10220250
BMJ Glob Health. 2017 Dec 1;3(Suppl 1):e000603
pubmed: 29379648
Psychiatr Serv. 2002 Dec;53(12):1499
pubmed: 12461203
Public Health. 2014 Jun;128(6):525-32
pubmed: 24916424
Clin Transl Sci. 2012 Feb;5(1):48-55
pubmed: 22376257
Cardiopulm Phys Ther J. 2010 Jun;21(2):4
pubmed: 20520757
J Gen Intern Med. 2019 Jun;34(6):1032-1038
pubmed: 30623387
Int J Public Health. 2014 Feb;59(1):3-14
pubmed: 24381979
Health Res Policy Syst. 2019 Aug 22;17(1):82
pubmed: 31438977
Health Promot Int. 2001 Sep;16(3):261-8
pubmed: 11509462
Implement Sci. 2021 Feb 15;16(1):18
pubmed: 33588878
Public Health Rep. 2021 Sep-Oct;136(5):523-531
pubmed: 34161180
Annu Rev Public Health. 2009;30:175-201
pubmed: 19296775
Clin Psychol (New York). 2016 Jun;23(2):180-200
pubmed: 29456295
Am J Prev Med. 2012 Jun;42(6):646-54
pubmed: 22608384
BMC Health Serv Res. 2020 Mar 12;20(1):190
pubmed: 32164706
Adv Health Sci Educ Theory Pract. 2021 Mar;26(1):19-35
pubmed: 32372393
Am J Public Health. 2015 Apr;105(4):665-9
pubmed: 25713962
Am J Prev Med. 2004 Dec;27(5):417-21
pubmed: 15556743
Implement Sci. 2020 Oct 15;15(1):89
pubmed: 33059748
Annu Rev Public Health. 2022 Apr 5;43:331-353
pubmed: 34982585
Bioscience. 2021 Apr 28;71(5):503-518
pubmed: 33986633
Implement Sci. 2016 Mar 08;11:30
pubmed: 26952719
Prev Sci. 2019 Nov;20(8):1147-1168
pubmed: 31444621
Ethn Dis. 2021 May 20;31(Suppl 1):357-364
pubmed: 34045837
J Epidemiol Community Health. 2003 Apr;57(4):254-8
pubmed: 12646539
Implement Sci. 2013 Sep 05;8:103
pubmed: 24007206
J Health Commun. 1996 Jul-Sep;1(3):267-83
pubmed: 10947364
Front Public Health. 2020 May 12;8:134
pubmed: 32478025
Am J Public Health. 2012 Jul;102(7):1267-73
pubmed: 22594719
Annu Rev Public Health. 2021 Apr 1;42:135-158
pubmed: 33467924
Implement Sci. 2018 May 29;13(1):72
pubmed: 29843737
JAMA. 2012 Apr 18;307(15):1583-4
pubmed: 22511682
BMC Med Res Methodol. 2021 Oct 25;21(1):225
pubmed: 34689742
Implement Sci. 2018 Sep 26;13(1):125
pubmed: 30257683
Health Promot Pract. 2012 Jul;13(4):559-66
pubmed: 22684264
J Clin Transl Sci. 2020 Jan 28;4(3):168-175
pubmed: 32695484
Am J Prev Med. 2011 Jun;40(6):637-44
pubmed: 21565657
Am J Public Health. 2012 Jul;102(7):1274-81
pubmed: 22594758
Health Educ Behav. 2001 Apr;28(2):231-48
pubmed: 11265831
Implement Sci. 2013 Feb 13;8:18
pubmed: 23406398
J Public Health Manag Pract. 1999 Sep;5(5):86-97
pubmed: 10558389
Implement Sci. 2016 Oct 19;11(1):141
pubmed: 27756414
J Eval Clin Pract. 2014 Dec;20(6):793-802
pubmed: 25130323
BMJ. 2015 May 08;350:h2147
pubmed: 25956159
J Acquir Immune Defic Syndr. 2008 Mar 1;47 Suppl 1:S40-6
pubmed: 18301133
Annu Rev Public Health. 2009;30:1-25
pubmed: 19296774

Auteurs

Ross C Brownson (RC)

Prevention Research Center, Brown School at Washington University in St. Louis, One Brookings Drive, Campus, Box 1196, St. Louis, MO, 63130, USA. rbrownson@wustl.edu.
Department of Surgery, Division of Public Health Sciences, and Alvin J. Siteman Cancer Center, Washington University School of Medicine, Washington University in St. Louis, St. Louis, MO, 63130, USA. rbrownson@wustl.edu.

Rachel C Shelton (RC)

Department of Sociomedical Sciences, Columbia University Mailman School of Public Health, New York, NY, 10032, USA.

Elvin H Geng (EH)

Division of Infectious Diseases, Department of Medicine and Center for Dissemination and Implementation in the Institute for Public Health, Washington University School of Medicine, Washington University in St. Louis, St. Louis, MO, 63110, USA.

Russell E Glasgow (RE)

Department of Family Medicine and Adult & Child Consortium for Health Outcomes Research and Delivery Science, University of Colorado School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH